% | $
Quotes you view appear here for quick access.

Omeros Corporation Message Board

  • rrtzrealmd rrtzrealmd Apr 2, 2013 9:39 AM Flag

    HAW!!! about desperate!...

    ...OMER released yet ANOTHER meaningless press release talking about "positive" data for their MASP-2 inhibitor:

    "...lead human monoclonal antibody in Omeros' mannan-binding lectin-associated serine protease-2 (MASP-2) program, in a well-established animal model of thrombotic microangiopathy (TMA), a disorder that occurs in the microcirculation (e.g., venules and capillaries) of the body's organs, most commonly the kidney and brain....The studies reported today were conducted to support the planned initial indication for OMS721 – aHUS."

    ...HAW!! DO they find this stuff?!!!...

    ...even considering this PR is little more than a rehash of the PR they issued just 5 DAYS AGO, the big question is -- WHO CARES?

    ...hemolytic uremic syndrome is about as rare a condition as you can imagine!...not only that, it is a condition from which 90% survive when treated with ALREADY AVAILABLE therapy!... other words, it's yet ANOTHER compound for which -- in the highly unlikley event it survived trials -- there will be practically NO MARKET!!!...

    ...great job, OMER!!..

    ...and they wonder why they can't seem to find any partners!...HAW, HAW, HAW!!!!...

    Sentiment: Strong Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • apple.kiddoo Apr 2, 2013 9:52 AM Flag

      You didn't answer me donkey, HAW HAW HAW. The question is YOUR MOM FINISHED THE VASELINE OVER THE WEEKEND OR NOT :D. People are not interested in what rubbish u say but only want to know how much Vaseline is left after her weekend fiasco !

      Sentiment: Strong Buy

11.04+0.09(+0.82%)9:49 AMEDT